Emanuele Puca

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Molecular cancer therapeutics

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Abdullah Elsayed, Louis Plüss, Larissa Nideroest, Giulia Rotta, Marina Thoma, Nathan Sébastien Zangger, Frederik Peissert, Stefanie K Pfister, Christian Pellegrino, Sheila Dakhel, Roberto De Luca, Markus Gabriel Manz, Annette Oxenius, Emanuele Puca, Cornelia Halin, Dario Neri
Optimizing the Design and Geometry of T Cell-Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer. Molecular cancer therapeutics 23 (7) (2024)
Abdullah Elsayed, Louis Plüss, Larissa Nideroest, Giulia Rotta, Marina Thoma, Nathan Sébastien Zangger, Frederik Peissert, Stefanie K Pfister, Christian Pellegrino, Sheila Dakhel, Roberto De Luca, Markus Gabriel Manz, Annette Oxenius, Emanuele Puca, Cornelia Halin, Dario Neri
Optimizing the design and geometry of T cell engaging bispecific antibodies targeting CEA in colorectal cancer. Molecular cancer therapeutics (2024)
Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Louis Plüss, Frederik Peissert, Abdullah Elsayed, Giulia Rotta, Jonas Römer, Sheila Dakhel, Alessandra Villa, Emanuele Puca, Roberto De Luca, Annette Oxenius, Dario Neri
Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen. mAbs 15 (1) (2023)
Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Abdullah Elsayed, Christian Pellegrino, Louis Plüss, Frederik Peissert, Ramon Benz, Franziska Ulrich, Gudrun Thorhallsdottir, Sheila Dakhel Plaza, Alessandra Villa, Jacqueline Mock, Emanuele Puca, Roberto De Luca, Markus Gabriel Manz, Cornelia Halin, Dario Neri
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties. mAbs 15 (1) (2023)
Tobias Weiss, Emanuele Puca, Manuela Silginer, Teresa Hemmerle, Shila Pazahr, Andrea Bink, Michael Weller, Dario Neri, Patrick Roth
Immunocytokines are a promising immunotherapeutic approach against glioblastoma. Science translational medicine 12 (564) (2021)
Emanuele Puca, Philipp Probst, Marco Stringhini, Patrizia Murer, Giovanni Pellegrini, Samuele Cazzamalli, Cornelia Hutmacher, Baptiste Gouyou, Sarah Wulhfard, Mattia Matasci, Alessandra Villa, Dario Neri
The antibody-based delivery of interleukin-12 to solid tumors boosts NK and CD8+ T cell activity and synergizes with immune checkpoint inhibitors. International journal of cancer 146 (9) (2019)